Email
USA TODAY panel says US has nailed the science behind COVID-19 vaccines, but logistics, trust remain a concern
Experts are concerned some won t trust the COVID-19 vaccine and are wary of production problems that could delay getting it to millions of Americans.
Karen Weintraub and Elizabeth Weise, USA TODAY
Published
12:12 am UTC Dec. 24, 2020
Experts are thrilled about the reported safety and effectiveness of two COVID-19 vaccines rolling out across the country. But they remain concerned about what still could go wrong to shake the public s fragile faith in it.
Nearly everything about the process has gone well so far, shepherded by the Trump administration s Operation Warp Speed.
Email
USA TODAY panel says US has nailed the science behind COVID-19 vaccines, but logistics, trust remain a concern
Experts are concerned some won t trust the COVID-19 vaccine and are wary of production problems that could delay getting it to millions of Americans.
Karen Weintraub and Elizabeth Weise, USA TODAY
Published
12:12 am UTC Dec. 24, 2020
Experts are thrilled about the reported safety and effectiveness of two COVID-19 vaccines rolling out across the country. But they remain concerned about what still could go wrong to shake the public s fragile faith in it.
Nearly everything about the process has gone well so far, shepherded by the Trump administration s Operation Warp Speed.
Recapping a wild first week.
By
Benjamin Cassidy
12/23/2020 at 8:00am
Straight to the freezer for the vaccine developed by Pfizer and BioNTech, which arrived at UW Medical Center on December 14.Â
MONday brought a much-needed boost in Washington s effort to curb the spread of Covid-19. The Seattle Indian Health Board received 500 doses of the coronavirus vaccine developed by biotech firm Moderna and the National Institutes of Health, and other health care providers will get their share of Washington s 128,000-dose allocation as the week progresses. Probably.
Skepticism about vaccine distribution abounds after a wild first week of vial divvying. Though the ModernaâNIH vaccine s approval process hewed to the same timeline as the PfizerâBioNTech shot s the week beforeâFDA authorization on Friday, an OK from the Western States Scientific Safety Review Workgroup on Sundayâjust about everyone hopes this rollout follows a different script than l
Email
USA TODAY panel says US has nailed the science behind COVID-19 vaccines, but logistics, trust remain a concern
Experts are concerned some won t trust the COVID-19 vaccine and are wary of production problems that could delay getting it to millions of Americans.
Karen Weintraub and Elizabeth Weise, USA TODAY
Published
12:12 am UTC Dec. 24, 2020
Experts are thrilled about the reported safety and effectiveness of two COVID-19 vaccines rolling out across the country. But they remain concerned about what still could go wrong to shake the public s fragile faith in it.
Nearly everything about the process has gone well so far, shepherded by the Trump administration s Operation Warp Speed.